Orthopedic Biomaterials Market (By Material Type: Polymers, Calcium Phosphate Cement, Composites, Metal, Ceramics and Bioactive Glasses; By Application: Orthobiologics, Orthopedic Implants, Viscosupplementation, Joint Replacement, Bio-resorbable Tissue Fixation; By End User) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2024- 2033
The global orthopedic biomaterials market size accounted for USD 21.38 billion in 2023 and is predicted to reach around USD 43.43 billion by 2033, expanding at a CAGR of 7.38% from 2024 to 2033. Increasing demand for orthopedic implants and rising injuries owing to sports and road calamities fuel the growth of the global orthopedic biomaterials market.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. orthopedic biomaterials market size was valued at USD 5.50 billion in 2023 and is estimated to reach around USD 11.69 billion by 2033, growing at a CAGR of 7.88% from 2024 to 2033.
Geographically, the global orthopedic biomaterials market is segmented into North America, Europe, Asia Pacific, and Middle East & Africa. North America is estimated to top the global market throughout the estimated time period. The growth in North America has been attributed to the increasing prevalence of various orthopedic surgeries. Growing number of patients requiring knee reconstruction or replacement and other orthopedic procedures are likely to enhance the growth of the market in the region. Europe holds the second largest position in the global orthopedic biomaterials market owing to rising research activities and availability of innovative treatments.
Asia Pacific is projected to witness fastest growth rate in the global orthopedic biomaterials market over the forecast period. This growth is owing to increased bone degenerative and disorders in developing nations such as India and China. India and China show robust growth on account of increasing population and subsequent rise in patient population. Growing expenditure on the healthcare and health infrastructure will further propel the growth of the orthopedic biomaterials market in the region. However, lack of knowledge, limited access to medical treatments results in less development in the Middle East and Africa. Nonetheless, gradual upsurge in spending for development of health care centers UAE (United Arab Emirates) may contribute to the growth in the Middle East during years to come.
The damaged bone has been reconstructed by using biomaterials caused by diseases or trauma. High occurrences of musculoskeletal disease will also drive the market growth of orthopedic biomaterials. Furthermore, significant rise in adoption of technologically advanced products and growth of R&D activities will boost the capabilities of orthopedic biomaterials which will in turn drive their demand in the market. Moreover, the orthopedic biomaterials market is driven by rising number of patients on account of growing number of geriatric population, increasing surgeries and growing health awareness among young generation. Rapidly increasing demand for next generation biomaterial products which are customized to meet the requirement of orthopedic procedure will further strengthen the growth of the market worldwide.
The increasing number of chronic diseases across emerging region such as Asia Pacific drives the market growth. The growth of orthopedic biomaterials rapidly increasing in China owing to it’s expanding population and subsequent rise in patient pool. Increasing health awareness and presence of new treatment methods in the region drives the growth of orthopedic biomaterials market. However, decreasing reimbursement for orthopedic implants owing to restricted reimbursement insurances hinders the growth of orthopedic biomaterials market. Moreover, with the emergence of advanced technology the biomaterials are customized to be used in 3D printing techniques may further offers alluring growth prospects for the market in the near future.
According to Census Bureau of United States the geriatric population (people above 65 age) has grown around 1.6 million from year 2014 to 2015. Rapidly increasing trauma incidences caused by fall, sports and accidents are pushing demand for orthopedic biomaterials has been increased. As population engaged in leisure operations and sports activities increases, the rate of accident is also expected to increase.
Report Highlights | Details |
Market Size in 2023 | USD 21.38 Billion |
Market Size by 2033 | USD 43.43 Billion |
Growth Rate from 2024 to 2033 | CAGR of 7.38% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | Material, Application, End User, Region |
Companies Mentioned | Acumed, LLC, Medtronic plc, Globus Medical, Inc., Stryker Corporation, Koninklijke DSM N.V., Exactech, Inc., Johnson & Johnson, Zimmer Biomet, Wright Medical Group, Inc., NuVasive, Inc. |
Based on the type of material the market has been classified into ceramics & bioactive glass, calcium phosphate cement, composites, metal and polymers. The ceramics & bioactive glass segment dominated the market in 2023 as ceramics are widely adopted in repair of hard tissues in multiple procedures. Owing to increasing use of polymer in bone cement as well as load bearing area for entire joint arthroplasties, the polymer segment is also projected to witness significant growth over the forecast period. These polymers are used in wide range of applications such as diagnostic support, drug delivery systems and useful material for tissue engineering.
Various applications of orthopedic biomaterials include joint orthobiologics, oerhopedic implants, joint replacement/ reconstruction, viscosupplementation along with the absorbable tissue fixation. The orthopedic implant segment dominated the market in 2023 and continuous to dominate the market over the forecast period. According to the American Society of Plastic Surgeons, biomaterials are widely used for plastic surgeries and the increasing demand for plastic surgeries across the globe is further escalate the biomaterials market.
Segments Covered in the Report
This research report incorporates complete review of the market with the help of broad qualitative and quantitative understandings, and projections regarding the market. This report presents breakdown of marketplace into potential and niche sectors. Further, this research study analyzes market revenue and its growth trend at global, regional, and country from 2021 to 2033. This report includes market segmentation and its revenue estimation by classifying it based on end-use and region as follows:
By Material Outlook
By Application Outlook
By End User
By Regional Outlook
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Orthopedic Biomaterials Market, By Material
7.1. Orthopedic Biomaterials Market, by Material Type, 2024-2033
7.1.1. Polymers
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Ceramics & Bioactive Glasses
7.1.2.1. Market Revenue and Forecast (2021-2033)
7.1.3. Calcium Phosphate Cement
7.1.3.1. Market Revenue and Forecast (2021-2033)
7.1.4. Composites
7.1.4.1. Market Revenue and Forecast (2021-2033)
7.1.5. Metal
7.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 8. Global Orthopedic Biomaterials Market, By Application
8.1. Orthopedic Biomaterials Market, by Application, 2024-2033
8.1.1. Orthobiologics
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Orthopedic Implants
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Viscosupplementation
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Joint Replacement
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Bio-resorbable Tissue Fixation
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Orthopedic Biomaterials Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Material (2021-2033)
9.1.2. Market Revenue and Forecast, by Application (2021-2033)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.1.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.1.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Material (2021-2033)
9.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Material (2021-2033)
9.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Material (2021-2033)
9.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Material (2021-2033)
9.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Material (2021-2033)
9.5.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Material (2021-2033)
9.5.4.2. Market Revenue and Forecast, by Application (2021-2033)
Chapter 10. Company Profiles
10.1. Acumed, LLC
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic plc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Globus Medical, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Stryker Corporation
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Koninklijke DSM N.V.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Exactech, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Johnson & Johnson
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Zimmer Biomet
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Wright Medical Group, Inc.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. NuVasive, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client